Enhanced bimatoprost ophthalmic solution
US7851504B2 · kind B2 · utility
22Cited by
7References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2005 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Jun 13, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.